Fig. 2From: Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolizationWasserman type 2, modified BPH classification 2 (retrourethral); AÂ T2-weighted axial baseline BÂ T2-weighted sagittal baseline; retrourethral dominant hyperplasia with pedunculated nodules; CÂ T2-weighted axial follow-up DÂ T2-weighted sagittal follow-up. Volume reduction of 95Â ml to 51Â ml (46%); IPSS 12 to 6 (50%)Back to article page